admin

BioHealth Innovation, Inc. (BHI) is a nonprofit organization focused on supporting BioHealth entrepreneurs and related industry growth in Montgomery County and the BioHealth Capital Region (Maryland, D.C. and Virginia).  BHI is seeking an energetic and motivated Marketing Intern to assist with communications and marketing-related projects. This position is estimated to be 15-25 hours per week, would start immediately, and continue for 12 weeks.  In addition to the responsibilities listed below, the intern may attend meetings and programs to understand the full work of BHI and how the organization accomplishes its mission through constituent outreach and support, commercialization and partnership activity.

StonebridgeCarras and The Donohoe Companies announced plans today for their project at 8280 Wisconsin Avenue which will focus its 175,000 square feet of commercial space on bringing life sciences to the Bethesda Central Business District (CBD).  StonebridgeCarras and Donohoe’s vision for the project is to capitalize on two converging trends:  employers locating their offices in live, work and play environments with access to mass transportation; and life sciences companies co-locating near thought leaders and institutions driving research and advancement.

Protenus has been selected by Modern Healthcare as one of the 2018 Best Places to Work in Healthcare. The complete list of this year’s winners, in alphabetical order, is available here. Modern Healthcare will publish a special supplement featuring ranked lists of all the winners along with the October 1 issue.

Paragon Bioservices, Inc. (Paragon), the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, was named the 2018 Life Science Company of the Year by the Maryland Tech Council (MTC). The announcement came at MTC’s 30th Annual Industry Awards held last night in the Hotel at the University of Maryland in College Park.

SoBran BioScience, a division of SoBran Inc, and a leading provider of pre-clinical GLP contract research announced the grand prize winner of the Innovation for Impact Prize sponsored in partnership with the Maryland Tech Council (MTC). This Grand Prize was awarded last night at the MTC 30th Anniversary Industry Awards Celebration.

AstraZeneca plc (LSE:AZN; NYSE:AZN) said FDA approved Lokelma sodium zirconium cyclosilicate (ZS-9) to treat hyperkalemia in adults. AZ had received two CRLs for Lokelma following manufacturing concerns (see BioCentury Extra, March 17, 2017).

Enthusiasm for the biopharmaceutical sector in Asia has been flat, due in part to China’s market-access blockade, Japan’s spending controls, and deceleration in India and Southeast Asia. Recent changes have reignited interest in the region, with important implications for pharma executives.

A nonprofit organization, Knowledge Ecology International (KEI), recently filed a lawsuit against the National Institutes of Health (NIH) over Gilead Sciences’ patents for a new chimeric antigen receptor T-cell (CAR-T) therapy.

KEI calls itself a “not for profit non government organization that searches for better outcomes, including new solutions, to the management of knowledge resources. KEI is focused on social justice, particularly for the most vulnerable populations, including low-income persons and marginalized groups.”

The U.S. Small Business Administration, under its Federal and State Technology (FAST) Partnership Program, is soliciting grant applications from New York organizations to help boost the development of technology from small businesses.